clonidine has been researched along with furosemide in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (43.48) | 18.7374 |
1990's | 8 (11.59) | 18.2507 |
2000's | 17 (24.64) | 29.6817 |
2010's | 13 (18.84) | 24.3611 |
2020's | 1 (1.45) | 2.80 |
Authors | Studies |
---|---|
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Michel, D | 1 |
Black, HR | 1 |
Faulhaber, HD; Linss, G | 1 |
Heidland, A; Röckel, A | 1 |
Riddiough, MA | 1 |
Bock, KD | 1 |
Bateman, FJ; Curtis, JR | 1 |
White, RP | 1 |
Liberman, TIu | 1 |
Campino, C; Lazcano, F; Marzullo, E; Orozco, R; Osorio, I; Passalaqua, W; Pla, C; Plaza de los Reyes, M | 1 |
Bock, KD; Günnewig, H; Werner, U | 1 |
Bradstock, K; Hunyor, SN; Lucas, N; Somerville, PJ | 1 |
Ramsey, L | 1 |
Pals, DT | 1 |
Kawasaki, H; Nakamura, S; Takasaki, K | 2 |
Jamet, M; Lévy, G; Lévy, PY; Toroyan, P | 1 |
Matney, J | 1 |
Liedtke, CM | 1 |
Distler, A; Fritschka, E; Hoyer, J; Kribben, A; Philipp, T; Rothschild, M; Thiede, HM | 1 |
Auzan, C; Choudat, L; Corvol, P; Dussaule, JC; Menard, J; Michel, JB; Nochy, D | 1 |
Almeyda, J; Levantine, A | 1 |
Elliott, RW; Kerr, DN; Pickering, M; Robson, V; Wilkinson, R | 1 |
Baglin, A; Merceron, R; Milliez, P; Safar, M; Sobel, A | 1 |
Câmpeanu, A; Teodoresco, P | 1 |
Finnerty, FA | 1 |
Khlebarova, M; Kiriakov, A; Panova, I; Staneva-Stoicheva, D | 1 |
Milliez, P; Safar, M; Sobel, A | 1 |
Alhenc-Gélas, F; Auzan, C; Corvol, P; Dussaule, JC; Ménard, J; Michel, JB | 1 |
Bartay, J; Benson, D; Peterson, LG | 1 |
Arita, M; Masuyama, Y; Mohara, O; Suruda, H; Ueno, Y | 1 |
Berkowitz, RL | 1 |
Wootton, DG | 1 |
Grim, CE | 1 |
Neuvonen, PJ; Roivas, L | 1 |
D'Hondt, A; Depierreux, M; Hanson, B; Lustman, F | 1 |
Antonio De Luca, L; Oliveira Margatho, L; Pereira Barbosa, S; Vanderlei Menani, J | 1 |
Gokee, A; Rocchini, AP; Yang, JQ | 1 |
Hennessy, A; Horvath, JS; Makris, A; Ogle, R; Thornton, C; Xu, B | 1 |
Füessl, HS | 1 |
Codden, T; Henry, JP; Lenaerts, A; Ligny, G; Meunier, JC | 1 |
Caeiro, XE; Godino, A; Vivas, L | 1 |
Anderson, FA; de La Garanderie, DP; Emery, L; Gore, JM; Rushton-Smith, S; Vincent, JL; Vuylsteke, A; Wyman, A | 1 |
Aragno, M; Mastrocola, R; Mengozzi, G; Parola, M; Sansoè, G | 1 |
Dyuizen, IV; Eliseeva, EV; Pigolkin, YI; Romanchenko, EF; Tyrtyshnikova, AV | 1 |
Barco, S; Bruschettini, M; Cangemi, G; Ley, D; Romantsik, O; Tripodi, G | 1 |
7 review(s) available for clonidine and furosemide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Management of high blood pressure using beta-sympatholytics. Review].
Topics: Adrenergic beta-Antagonists; Clonidine; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Spironolactone | 1976 |
[Current treatment of arterial hypertension].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Clonidine; Dihydralazine; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Reserpine | 1977 |
Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone | 1977 |
Your patient and angina.
Topics: Angina Pectoris; Clonidine; Drug Interactions; Female; Flurazepam; Furosemide; Humans; Hypertension; Middle Aged; Nadolol; Nitroglycerin; Patient Care Planning | 1991 |
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; Drug Eruptions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Mercury; Methyldopa; Nitroglycerin; Pentaerythritol Tetranitrate; Procainamide; Quinidine; Thiazines | 1973 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Infant Mortality; Methyldopa; Nitroprusside; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Secologanin Tryptamine Alkaloids; Sodium; Sodium Chloride Symporter Inhibitors | 1980 |
3 trial(s) available for clonidine and furosemide
Article | Year |
---|---|
Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.
Topics: Adult; Aged; Antihypertensive Agents; Chlorothiazide; Clinical Trials as Topic; Clonidine; Drug Evaluation; Drug Therapy, Combination; Edetic Acid; Female; Furosemide; Humans; Hypertension, Renal; Hypotension, Orthostatic; Kidney Failure, Chronic; Kidney Transplantation; Male; Methyldopa; Middle Aged; Piperazines; Propranolol; Quinazolines | 1975 |
The use of frusemide and propranool in the treatment of the hypertension of chronic renal disease.
Topics: Administration, Oral; Blood Pressure; Clinical Trials as Topic; Clonidine; Creatinine; Furosemide; Homeostasis; Humans; Hypertension, Renal; Methyldopa; Natriuresis; Propranolol; Renin; Sodium | 1974 |
Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
Topics: Angiotensins; Ascites; Clonidine; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Norepinephrine; Renin; Spironolactone; Sympathetic Nervous System; Sympatholytics | 2006 |
59 other study(ies) available for clonidine and furosemide
Article | Year |
---|---|
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Management of hypertension.
Topics: Adrenergic alpha-Antagonists; Benzothiadiazines; Clonidine; Diuretics; Ethacrynic Acid; Furosemide; Humans; Hypertension; Methyldopa; Patient Care Planning; Patient Compliance; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Trimethaphan; Vascular Resistance; Vasodilator Agents | 1977 |
[Saralasin in resistant hypertensive crisis (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Clonidine; Female; Furosemide; Glomerulonephritis; Humans; Hypertension; Hypertension, Renovascular; Male; Pheochromocytoma; Renin; Saralasin | 1979 |
[Treatment of hypertensive emergencies].
Topics: Clonidine; Diazoxide; Emergencies; Family Practice; Furosemide; Hospitalization; Humans; Hypertension; Nitroprusside; Phentolamine; Renal Dialysis; Reserpine | 1978 |
Drugs for hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Depression; Diuretics; Drug Combinations; Drug Therapy, Combination; Furosemide; Guanethidine; Humans; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Potassium; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Vasodilator Agents; Water-Electrolyte Imbalance | 1977 |
Antihypertensive agents in renal disease.
Topics: Antihypertensive Agents; Body Water; Clonidine; Diazoxide; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hypertension, Renal; Kidney Failure, Chronic; Methyldopa; Renal Dialysis; Renin; Reserpine; Saralasin; Teprotide; Vasodilator Agents | 1977 |
[Clinical evaluation of the hypotensive drug catapresan].
Topics: Adult; Antihypertensive Agents; Clonidine; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Humans; Male; Middle Aged; Reserpine; Strophanthins | 1977 |
[Use of clonidine, furosemide and propranolol in the treatment of different phases of hypertension (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Clonidine; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Propranolol | 1977 |
Relationships between plasma renin activity and urinary and plasma catecholamines.
Topics: Blood Pressure; Clonidine; Dihydralazine; Furosemide; Humans; Hypertension; Hypertension, Renal; Norepinephrine; Renin | 1975 |
Clonidine overdose.
Topics: Adolescent; Clonidine; Diazoxide; Diuresis; Female; Furosemide; Heart Rate; Humans; Hypertension | 1975 |
Letter: Treatment of clonidine overdose.
Topics: Clonidine; Furosemide; Humans | 1975 |
Hypotensive effect of clonidine during sodium depletion in the rat.
Topics: Animals; Blood Pressure; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Furosemide; Heart Rate; Hydroxydopamines; Hypertension; Hyponatremia; Hypotension; Male; Nephrectomy; Rats; Renin; Saralasin | 1975 |
Central alpha 2-adrenoceptor-mediated pressor response to clonidine in conscious, spontaneously hypertensive rats.
Topics: Anesthesia; Animals; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Furosemide; Heart Rate; Hypertension; Injections, Intraventricular; Male; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Water Deprivation; Yohimbine | 1992 |
[Thrombocytopenia induced by low molecular weight heparin during hypotensive and diuretic treatment: coincidence or connection?].
Topics: Adverse Drug Reaction Reporting Systems; Aged; Clonidine; Drug Therapy, Combination; Female; Furosemide; Heparin, Low-Molecular-Weight; Humans; Thrombocytopenia | 1991 |
Furosemide inhibits the centrally-mediated pressor response to clonidine in conscious, normotensive rats.
Topics: Animals; Blood Pressure; Body Fluids; Clonidine; Furosemide; Heart Rate; Injections, Intraventricular; Male; Norepinephrine; Rats; Rats, Inbred Strains | 1991 |
Calcium and alpha-adrenergic regulation of Na-Cl(K) cotransport in rabbit tracheal epithelial cells.
Topics: Animals; Bumetanide; Calcium; Carrier Proteins; Cells, Cultured; Chlorides; Clonidine; Epinephrine; Epithelium; Furosemide; Isoproterenol; Kinetics; Rabbits; Receptors, Adrenergic, alpha; Sodium; Sodium-Potassium-Chloride Symporters; Trachea; Yohimbine | 1990 |
Regulation of alpha 2-adrenoceptor density in normotensive and hypertensive man.
Topics: Adenylyl Cyclases; Blood Platelets; Clonidine; Furosemide; Humans; Hypertension; Male; Nifedipine; Norepinephrine; Receptors, Adrenergic, alpha | 1987 |
Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Clonidine; Dihydralazine; Drug Therapy, Combination; Furosemide; Hydralazine; Hypertension, Renovascular; Indoles; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Time Factors | 1986 |
[Treatment of arterial hypertension with new drugs. 1. Severe arterial hypertension].
Topics: Antihypertensive Agents; Body Weight; Clonidine; Diuresis; Furosemide; Hemodynamics; Humans; Hypertension; Methyldopa; Sodium; Sodium Chloride; Spironolactone; Urea | 1972 |
[Effects of clonidine treatment in advanced forms of essential arterial hypertension].
Topics: Aged; Aortic Arch Syndromes; Bradycardia; Cerebral Hemorrhage; Chemical Phenomena; Chemistry; Chlorthalidone; Clonidine; Drug Therapy, Combination; Female; Furosemide; Hemiplegia; Humans; Hypertension; Ischemia; Kidney Failure, Chronic; Male; Middle Aged; Retinal Hemorrhage | 1973 |
Drugs used in the treatment of hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ethacrynic Acid; Ferricyanides; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Nitric Oxide; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Vasodilator Agents | 1973 |
[The effect of prolonged treatment hypertensive rats with antihypertensive agents with different mechanisms of action on blood pressure and noradrenaline concentration in the myocardium, brain and aorta].
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Brain Chemistry; Clonidine; Disulfiram; Furosemide; Guanethidine; Hypertension; Male; Methyldopa; Myocardium; Norepinephrine; Rats; Reserpine | 1973 |
[Water-sodium depletion and clonidine in severe arterial hypertension].
Topics: Adult; Antihypertensive Agents; Body Weight; Clonidine; Creatinine; Drug Synergism; Electrocardiography; Female; Furosemide; Humans; Hypertension; Hyponatremia; Imidazoles; Kidney Function Tests; Male; Middle Aged; Nitrogen; Spironolactone; Water-Electrolyte Balance | 1972 |
[Comparison of the cardiac, renal and endocrine effects of converting enzyme inhibition with those of a classical triple therapy in experimental renal hypertension].
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Volume; Clonidine; Dihydralazine; Drug Therapy, Combination; Furosemide; Heart Ventricles; Hydralazine; Hypertension, Renovascular; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1984 |
Neuropsychiatric manifestations of antihypertensive medications.
Topics: Adrenergic beta-Antagonists; Affective Symptoms; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Prazosin; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors | 1983 |
Contributions of central sympathetic neural activity to furosemide-induced increases in plasma renin activity and noradrenaline.
Topics: Aldosterone; Animals; Blood Pressure; Central Nervous System; Clonidine; Dogs; Female; Furosemide; Heart Rate; Male; Norepinephrine; Renin; Sympathetic Nervous System | 1983 |
A fatality due to drug synergism.
Topics: Adult; Cardiomyopathies; Clonidine; Death, Sudden; Drug Synergism; Female; Furosemide; Humans; Hypokalemia; Thioridazine | 1982 |
Management of malignant hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Furosemide; Humans; Hydralazine; Hypertension, Malignant; Injections, Intravenous; Minoxidil; Nitroprusside; Propranolol; Pulmonary Edema; Time Factors; Uremia | 1980 |
Drug adsorption onto activated charcoal as a means of formulation.
Topics: Adsorption; Albuterol; Charcoal; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Clonidine; Furosemide; Kinetics; Metoprolol; Pindolol; Sympatholytics | 1994 |
Nephrotic syndrome after norfloxacin.
Topics: Aged; Amlodipine; Anti-Infective Agents; Antihypertensive Agents; Clonidine; Creatinine; Diuretics; Female; Furosemide; Humans; Indomethacin; Isosorbide Dinitrate; Lisinopril; Nephrotic Syndrome; Norfloxacin; Proteinuria; Urinary Tract Infections | 1996 |
Central serotonergic and adrenergic/imidazoline inhibitory mechanisms on sodium and water intake.
Topics: Amphetamines; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebellar Nuclei; Clonidine; Diuretics; Drinking; Drinking Behavior; Furosemide; Idazoxan; Imidazoline Receptors; Injections, Intraventricular; Male; Methysergide; Rats; Rats, Sprague-Dawley; Receptors, Drug; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride, Dietary | 2002 |
Hypertension and insulin resistance are not directly related in obese dogs.
Topics: Adrenergic beta-Antagonists; Animals; Aspirin; Atenolol; Blood Glucose; Clonidine; Diet, Sodium-Restricted; Dietary Fats; Dogs; Female; Furosemide; Hemodynamics; Hypertension; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Models, Animal; Models, Biological; Obesity; Prazosin; Protein Serine-Threonine Kinases; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathetic Nervous System | 2004 |
Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy.
Topics: Antihypertensive Agents; Cell Culture Techniques; Cells, Cultured; Clonidine; Culture Media, Conditioned; Cytokines; Diazoxide; Dose-Response Relationship, Drug; Female; Furosemide; Gestational Age; Glucose; Humans; Hydralazine; Leukocytes, Mononuclear; Lipopolysaccharides; Organ Culture Techniques; Placenta; Pregnancy; Pregnancy Proteins; Pregnancy Trimester, Third | 2006 |
[Emergency checklist in hypertensive crisis].
Topics: Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Clonidine; Diuretics; Emergencies; Female; Furosemide; Hospitalization; Humans; Hypertension; Male; Medical History Taking; Nifedipine; Nitrendipine; Pregnancy; Vasodilator Agents | 2006 |
β-Endorphinergic system involvement in the inhibitory action of clonidine on induced sodium appetite.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Appetite; beta-Endorphin; Clonidine; Drinking; Furosemide; Imidazoline Receptors; Mice; Mice, Inbred Strains; Receptors, Adrenergic, alpha-2; Sodium Chloride, Dietary | 2011 |
Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT).
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Clonidine; Emergency Service, Hospital; Europe; Female; Furosemide; Hospital Mortality; Humans; Hypertension; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Nitroglycerin; Perioperative Care; Piperazines; Practice Patterns, Physicians' | 2011 |
Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine.
Topics: Adrenergic Agonists; Animals; Ascites; Canrenoic Acid; Clonidine; Diuretics; Drug Synergism; Fibrosis; Furosemide; Guanfacine; Male; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2016 |
Effect of Hypotensive Drugs on Dynamics of Nitroxide-Producing Renal Function in Rats with Nephrogenic Hypertension.
Topics: Animals; Animals, Outbred Strains; Antihypertensive Agents; Benzimidazoles; Clonidine; Furosemide; Gene Expression Regulation; Hypertension, Renal; Kidney Glomerulus; Kidney Tubules, Collecting; Male; NADPH Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase; Rats; Renin; Time Factors; Vasodilation | 2017 |
A LC-MS/MS method for the quantification of caffeine, betamethasone, clonidine and furosemide in cerebrospinal fluid of preterm infants.
Topics: Betamethasone; Caffeine; Chromatography, Liquid; Clonidine; Female; Furosemide; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Reproducibility of Results; Tandem Mass Spectrometry | 2020 |